Mesoblast (MESO) Share-based Compensation Growth (1y) (2017 - 2023)
Mesoblast (MESO) Share-based Compensation Growth (1y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 118.32% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -40.86% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -58.13% |
| Dec 31, 2022 | -4.93% |
| Sep 30, 2022 | -67.47% |
| Jun 30, 2022 | -47.29% |
| Mar 31, 2022 | -6.44% |
| Dec 31, 2021 | -58.19% |
| Sep 30, 2021 | -77.96% |
| Jun 30, 2021 | -30.88% |
| Mar 31, 2021 | -2.93% |
| Dec 31, 2020 | 115.46% |
| Sep 30, 2020 | 507.09% |
| Jun 30, 2020 | 160.21% |
| Mar 31, 2020 | 74.64% |
| Dec 31, 2019 | 36.01% |
| Sep 30, 2019 | -1.71% |
| Jun 30, 2019 | 26.48% |
| Mar 31, 2019 | -5.48% |
| Dec 31, 2018 | -43.55% |
| Sep 30, 2018 | -56.70% |
| Jun 30, 2018 | -71.18% |